The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -19.57 — distress zone — historically elevated failure riskWatch
- Earnings-manipulation signal · Beneish M 0.01 — flag raised, worth a closer lookWatch
- Earnings quality 75/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as NEUROONE MEDICAL TECHNOLOGIES Corp reports it. History and quarterly detail are in the app.
- One RF Ablation System Revenue$9.1M
Leadership changes
From NEUROONE MEDICAL TECHNOLOGIES Corp's own filings, the day they're filed.
- Christopher Volker · Chief Operating Officer · departureeff. 2026-07-01
- Ronald McClurg · Chief Financial Officer · departureeff. 2026-04-24
- Christopher R. Volker · Chief Operating Officer · appointmenteff. 2023-11-14
Latest filings
- 8-K · Company announcement2026-06-12
- 8-K · Company announcement2026-05-22
- 8-K · Company announcement2026-05-12
- 10-Q · Quarterly report2026-05-12
- 8-K · Company announcement2026-05-04
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, every figure source-linked🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask anything about NEUROONE MEDICAL TECHNOLOGIES Corp, every answer cited🔒
- The Intelligence Brief — added when NEUROONE MEDICAL TECHNOLOGIES Corp's brief passes our SEC-figure check🔒
Every figure links to the filing it came from, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.